Activated point mutants of FGFR2

Click on a node on the pathway to see its details. Glycoproteins are marked with a glycoprotein icon in their name.
FGFR2 ligand-independent mutantsFGFR2 ligand-independent mutant dimersActivated FGFR2 ligand-independent mutantsATPADPFGFR2b mutants with enhanced ligand bindingFGFR2b mutant dimers with enhanced ligand-binding bound to FGFsHSFGFR2b mutant-binding FGFsActivated FGFR2b mutants with enhanced ligand bindingFP-1039FGFR2b mutant-binding FGFs:FP-1039FGFR2c mutants with enhanced ligand bindingFGFR2c mutant dimers with enhanced ligand-binding bound to FGFsFGFR2c mutant binding FGFsActivated FGFR2c mutants with enhanced ligand-bindingFGFR2 mutants with enhanced kinase activityFGFR2 mutant dimers with enhanced kinase activityActivated FGFR2 mutants with enhanced kinase activityFGFR2 point mutant dimersFGFR2 point mutant dimers:TKIsTyrosine kinase inhibitors of FGFR2 mutants
ProteinProtein familyDNARNAComplexChemical/MoleculePhenotype/StimulusNucleusMitochondriaEndosomeGolgi apparatusLysosomeMembraneUp-regulatesDown-regulatesPhysical interactionUnknownDirectIndirectBindingHighlight
a simple tooltip

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025